Home » Topics » Regulatory » Patents

Patents
RSS

More work at P&G on metalloprotease inhibitors

June 4, 1998

Byk Gulden's new PDE IV inhibitors

June 4, 1998

Dopaminergic agents for schizophrenia described by AHP

June 4, 1998

Genetics Institute claims series with PLA2-inhibitory activity

June 4, 1998

Nikken Chemicals presents new antiasthmatic agents

June 3, 1998

Compounds for schizophrenia without EPS developed at AHP

June 3, 1998

Antimicrotubule cryptophycins developed by Lilly, U.S. university researchers

June 3, 1998

Procter & Gamble prepares inhibitors of mammalian metalloproteases

June 3, 1998

New Lilly compounds for postmenopausal syndrome

June 3, 1998

Inhibitors of cysteine protease from SKB for bone and cartilage disorders

June 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...